Clinical trial
Study of the Relationship Between the Rate of Residual Platinum in the Blood and the Incidence of Persistent Neurotoxicity in Patients Treated for Gastrointestinal Cancer With Oxaliplatin
NCT00274885 is registered in ClinicalTrials.gov with GERCOR - Multidisciplinary Oncology Cooperative Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of the Relationship Between the Rate of Residual Platinum in the Blood and the Incidence of Persistent Neurotoxicity in Patients Treated for Gastrointestinal Cancer With Oxaliplatin
- Lead sponsor
- GERCOR - Multidisciplinary Oncology Cooperative Group
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- October 31, 2005
- Completion date
- Not reported
- Enrollment
- 58 (estimated)
- Sites
- 6
Conditions
As the registry lists them; a condition with its own page is linked.
cancer